Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026 and Sep 2026.
- Largest single sale: $334K (13,200 shares) of Immunome Inc. on Sep 11, 2026. Filing
- Last sale before this period: Aug 15, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunome Inc. (IMNM) | Chief Scientific Officer | Oct 12, 2023 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 11, 2026, Immunome Inc.: sold 13,200 shares for $334K, under a disclosed plan; 18,000 shares acquired by exercising options; 8,800 shares given away. 1 filing: 1
- Jul 23, 2026, Immunome Inc.: 38,250 shares granted. 1 filing: 1
- Apr 2, 2026, Immunome Inc.: sold 9,438 shares for $204K, under a disclosed plan. 1 filing: 1
- Mar 30, 2026, Immunome Inc.: 6,291 shares given away. 1 filing: 1
- Dec 19, 2025, Immunome Inc.: 6,000 shares moved between their own holdings (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.